Eric Rubin Buys Shares of Natera, Inc.
Eric Rubin purchased 75 shares of Natera, Inc. on June 26, 2026.
Key Points
- Eric Rubin bought 75 shares of Natera, Inc. on June 26, 2026, in an unplanned transaction.
- Natera, Inc. shares traded near $267.05 on Wednesday, with a market cap of $37.51 billion and a 52-week high of $271.47.
- Analysts from firms like Guggenheim and Bernstein maintain strong buy ratings with targets as high as $310.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Eric Rubin recently bought 75 shares of Natera, Inc. on June 26, 2026. This purchase was not part of a pre-planned transaction. As of Wednesday, shares of Natera traded near $267.05 on the NasdaqGS.
Insider Buying and Selling at Natera, Inc.
On June 26, 2026, several insiders at Natera, Inc. made stock purchases. Baynes Roy acquired 1,646 shares, while Roelof Botha purchased 1,691 shares. Thomas Jr. Lynch added 1,905 shares to his holdings, and Rowan Chapman bought 1,674 shares. Gail Boxer Marcus also acquired 1,669 shares. These transactions were not part of pre-arranged trading plans.
Other Institutional Activity in Natera, Inc.
JPMorgan Chase & Co. increased its holdings in Natera by 532,333 shares, bringing its total to 13,386,667 shares worth about $2.5 billion. Price T Rowe Associates, Inc. added 1,312,887 shares, ending with 12,184,876 shares valued at approximately $2.44 billion. BlackRock, Inc. slightly reduced its position by 182,103 shares, holding 10,677,338 shares worth $2.14 billion. Vanguard Capital Management LLC opened a new position with 6,008,496 shares valued at $1.2 billion. Similarly, Vanguard Portfolio Management LLC initiated a stake with 5,644,695 shares worth approximately $1.13 billion.
Natera, Inc. Stock Down 13.7%
Shares of Natera, Inc. (NasdaqGS:NTRA) traded near $267.05 on Wednesday. The company has a market cap of $37.51 billion. Although not currently profitable, it has a beta of 1.544, indicating higher volatility compared to the market. The stock's 52-week low is $131.81, with a high of $271.47. Its 50-day moving average is $212.40, and the 200-day moving average is $208.58. Natera maintains a healthy current ratio of 2.959 and a quick ratio of 2.697, with a debt-to-equity ratio of 13.533.
$NTRA stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 29, 2026, Guggenheim maintained a buy rating for Natera with a $290 price target. Bernstein reiterated its buy rating on June 26, setting a target of $310. BTIG maintained its buy rating with a $275 target on June 24. Barclays also maintained a buy rating, targeting $260. The consensus among 21 analysts is a strong buy, with an average target price of $262.67.
About Natera, Inc.
Natera, Inc. is a healthcare company based in Austin, Texas, specializing in diagnostics and research. It provides a variety of molecular testing services, including personalized ctDNA blood tests for cancer patients and non-invasive prenatal testing. The company collaborates with pharmaceutical companies and medical centers worldwide. Steven Leonard Chapman serves as CEO, leading a workforce of over 6,100 employees.
Bottom Line
Insider purchases at Natera, Inc. suggest confidence in the company's future prospects. Despite current unprofitability, Natera is a significant player in the diagnostics sector with its innovative testing services. The stock's recent trading activity and strong institutional interest highlight its potential, though investors should note that insider activity is just one of many factors to consider.
Get Natera, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NTRA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.